Role of streptococcus pneumoniae in hospitalization for acute community-acquired pneumonia associated with culture-confirmed mycobacterium tuberculosis in children: A pneumococcal conjugate vaccine probe study

Pediatric Infectious Disease Journal

Volumn 29, Issue 12, 2010, Pages 1099-1104

  Moore, David P ^a   Klugman, Keith P ^b,c,d   Madhi, Shabir A ^d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

HIV; pneumococcal vaccine; pneumococcus; pneumonia; tuberculosis

Indexed keywords

9 VALENT PNEUMOCOCCAL POLYSACCHARIDE PROTEIN CONJUGATE VACCINE; BCG VACCINE; PLACEBO; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM CULTURE; BCG VACCINATION; CHILD; CLINICAL EVALUATION; COMMUNITY ACQUIRED PNEUMONIA; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FOLLOW UP; HOSPITALIZATION; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION RISK; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PHASE 3 CLINICAL TRIAL; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOUTH AFRICA; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

EID: 78650389688     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181eaefff     Document Type: Article

References (36)

1. Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet. 2002;360:985-990.
2. Ansari NA, Kombe AH, Kenyon TA, et al. Pathology and causes of death in a series of human immunodeficiency virus-positive and -negative pediatric referral hospital admissions in Botswana. Pediatr Infect Dis J. 2003; 22:43-47.
3. Hesseling AC, Schaaf HS, Gie RP, et al. A critical review of diagnostic approaches used in the diagnosis of childhood tuberculosis. Int J Tuberc Lung Dis. 2002;6:1038-1045.
4. Jeena PM, Pillay P, Pillay T, et al. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. Int J Tuberc Lung Dis. 2002;6:672-678.
5. Madhi SA, Petersen K, Madhi A, et al. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis. 2000;31:170-176.
6. Zar HJ, Apolles P, Argent A, et al. The etiology and outcome of pneumonia in human immunodeficiency virus-infected children admitted to intensive care in a developing country. Pediatr Crit Care Med. 2001;2:108-112.
7. McNally LM, Jeena PM, Gajee K, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet. 2007;369:1440-1451.
8. Silverman M, Stratton D, Diallo A, et al. Diagnosis of acute bacterial pneumonia in Nigerian children. Value of needle aspiration of lung of countercurrent immunoelectrophoresis. Arch Dis Child. 1977;52:925-931.
9. Black SB, Shinefield HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002;21:810-815.
10. Ulloa-Gutierrez R, Avila-Aguero ML. 6th International Symposium on Pneumococci and Pneumococcal Diseases. Expert Rev Vaccines. 2008;7: 725-728.
11. Starke JR. Pediatric tuberculosis: time for a new approach. Tuberculosis (Edinb). 2003;83:208-212.
12. Zar HJ, Hanslo D, Apolles P, et al. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet. 2005;365:130-134.
13. Mulholland K, Hilton S, Adegbola R, et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Lancet. 1997;349:1191-1197. (Pubitemid 27190041)
14. Black S, Shinefield H, Fireman B, et al; Northern California Kaiser Permanente Vaccine Study Center Group. Efficacy, safety, and immuno-genicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187-195.
15. Madhi SA, Klugman KP. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med. 2004;10:811-813.
16. Madhi SA, Kuwanda L, Cutland C, et al. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis. 2005;40:1511-1518.
17. Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumo-coccal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 2005;365:1139-1146. (Pubitemid 40417563)
18. Mulholland K. Use of vaccine trials to estimate burden of disease. J Health Popul Nutr. 2004;22:257-267.
19. Klugman KP, Madhi SA, Huebner RE, et al. A trial of a 9-valent pneumo-coccal conjugate vaccine in children with and those without HIV infection. N Engl J Med. 2003;349:1341-1348.
20. Madhi SA, Adrian P, Kuwanda L, et al. Long-term immunogenicity and efficacy of a 9-valent conjugate pneumococcal vaccine in human immuno-deficient virus infected and non-infected children in the absence of a booster dose of vaccine. Vaccine. 2007;25:2451-2457.
21. Health Systems Research and Epidemiology. Summary Report: National HIV Seroprevalence Survey of Women Attending Antenatal Clinics in South Africa. Pretoria, South Africa: V & R Printing Works; 2001.
22. Gray GE, McIntyre JA, Lyons SF. Effect of breastfeeding on vertical transmission of HIV-1 in Soweto, South Africa. Presented at: 11th International Conference on AIDS; 1997; Vancouver, BC, Canada.
23. Health Systems Trust. South African health indicators: tuberculosis. Available at: http://www.hst.org.za/indicators/TB/. Accessed July 7, 2009.
24. Osborne CM. The challenge of diagnosing childhood tuberculosis in a developing country. Arch Dis Child. 1995;72:369-374.
25. Houwert KA, Borggreven PA, Schaaf HS, et al. Prospective evaluation of World Health Organization criteria to assist diagnosis of tuberculosis in children. Eur Respir J. 1998;11:1116-1120.
26. Stop TB Partnership Childhood TB Subgroup; World Health Organization. Guidance for National Tuberculosis Programmes on the management of tuberculosis in children. Chapter 1: introduction and diagnosis of tuberculosis in children. Int J Tuberc Lung Dis. 2006;10:1091-1097.
27. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004;8:392-402.
28. Pedrosa J, Saunders BM, Appelberg R, et al. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect Immun. 2000;68:577-583.
29. Dudani R, Murali-Krishna K, Krishnan L, et al. IFN-gamma induces the erosion of preexisting CD8 T cell memory during infection with a heter-ologous intracellular bacterium. J Immunol. 2008;181:1700-1709.
30. Jo EK. Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs. Curr Opin Infect Dis. 2008;21:279-286.
31. Barkman C, Martner A, Hessle C, et al. Soluble bacterial constituents down-regulate secretion of IL-12 in response to intact Gram-positive bacteria. Microbes Infect. 2008;10:1484-1493.
32. Scott JA, Hall AJ, Muyodi C, et al. Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet. 2000;355: 1225-1230.
33. Schleicher GK, Feldman C. Dual infection with Streptococcus pneumoniae and Mycobacterium tuberculosis in HIV-seropositive patients with community acquired pneumonia. Int J Tuberc Lung Dis. 2003;7:1207-1208.
34. Ntwaza MC. Evaluation of Treatment Adequacy of Culture Confirmed Pulmonary Tuberculosis in a Tertiary Hospital Chris Hani Baragwanath Hospital. Johannesburg (Gauteng), South Africa: Department of Paediatrics and Child Health, University of the Witwatersrand; 2004.
35. Edginton ME, Rakgokong L, Verver S, et al. Tuberculosis culture testing at a tertiary care hospital: options for improved management and use for treatment decisions. Int J Tuberc Lung Dis. 2008;12:786-791.
36. Engelbrecht AL, Marais BJ, Donald PR, et al. A critical look at the diagnostic value of culture-confirmation in childhood tuberculosis. J Infect. 2006;53:364-369.